Drug Trial Radar · NCT04764643
The Efficacy of N-acetylcysteine on Alleviating Symptom Caused by Lugol Chromoendoscopy
Last checked: Nov 19, 2026Latest source record: Jan 30, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
140
Actual
Start
Feb 1, 2020
Primary completion
Apr 30, 2021
Study completion May 31, 2021
Sponsor
- Lead sponsor
- Xijing Hospital of Digestive DiseasesAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Feb 21, 2021
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Diagnostic
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Lugol chromoendoscopy is essential in detecting and characterizing squamous cell carcinoma of esophagus. Esophageal irritating symptom has been reported as an common adverse event, which could be alleviated by sodium thiosulfate solutions. However, sodium thiosulfate was not widely available. N-acetylcysteine has been previously used as a mucolytic reagent, we propose that it may also be used to alleviate irritating symptoms caused by Lugo's chromoendoscopy. A prospective, non-inferior, randomized double-blind clinical trial was designed to study the efficacy of N-acetylcysteine solutions in relieving esophageal discomfort .
Conditions
- Esophageal Squamous Cell Carcinoma
Interventions
N-acetylcysteine solutionDrug
use N-acetylcysteine solution to alleviate esophageal irritation caused by Lugol's chromoendoscopy
sodium thiosulfate solutionDrug
use sodium thiosulfate solution to alleviate esophageal irritation caused by Lugol's chromoendoscopy
Primary outcomes
What the sponsor says the trial is designed to measure.
- Mean Visual analogue scale changeTime frame: 30 minute after endoscopy
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Xijing Hospital of Digestive Disease
Xi'an, Shaanxi, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.